Edition:
United Kingdom

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.20USD
12 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.20
Open
$1.25
Day's High
$1.26
Day's Low
$1.20
Volume
4,277
Avg. Vol
17,786
52-wk High
$2.25
52-wk Low
$1.14

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.159
Mar '18 0.00 -0.117
FY 2017 Dec '17 0.00 -0.175
Sep '17 0.00 -0.907
Jun '17 0.00 -0.504
Mar '17 0.00 -0.376
FY 2016 Dec '16 0.28 -0.678
Sep '16 0.20 -0.862
Jun '16 0.22 -1.005
Mar '16 0.14 -1.042
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.67 2.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 3 -0.17 -0.13 -0.21 --
Quarter Ending Mar-19 1 -0.16 -0.16 -0.16 --
Year Ending Dec-18 3 -0.61 -0.55 -0.66 --
Year Ending Dec-19 3 -0.65 -0.37 -0.91 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 81.01 29.57
P/E High - Last 5 Yrs. -- 267.91 46.44
P/E Low - Last 5 Yrs. -- 85.11 24.51
Beta 3.24 0.74 0.88
Price to Sales (TTM) -- 232.78 15.43
Price to Book (MRQ) 0.81 16.33 4.06
Price to Tangible Book (MRQ) 0.81 20.88 13.80
Price to Cash Flow (TTM) -- 48.95 21.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.40 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.45
Dividend 5 Year Growth Rate -- 3.72 -5.78
Payout Ratio(TTM) -- 7.81 41.88

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 148.87 7.10
Sales (TTM) vs TTM 1 Yr. Ago -100.00 63.88 5.63
Sales - 5 Yr. Growth Rate -- 22.16 7.39
EPS (MRQ) vs Qtr. 1 Yr. Ago 68.57 46.11 36.31
EPS (TTM) vs TTM 1 Yr. Ago 43.95 -- --
EPS - 5 Yr. Growth Rate -- 20.32 7.73
Capital Spending - 5 Yr. Growth Rate 1.61 34.35 8.00

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.36 2.55
Current Ratio (MRQ) 5.68 6.59 3.51
LT Debt to Equity (MRQ) 0.00 18.51 11.13
Total Debt to Equity (MRQ) 0.00 23.97 14.84
Interest Coverage (TTM) -268.82 -205.37 40.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.29 54.38
Gross Margin - 5 Yr. Avg. -- 47.38 52.96
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,420.21 -162.73 15.85
Operating Margin (TTM) -- -1,819.18 -16.28
Operating Margin - 5 Yr. Avg. -1,431.26 -175.96 11.08
Pre-Tax Margin (TTM) -- -1,749.43 -14.67
Pre-Tax Margin - 5 Yr. Avg. -1,306.91 -178.84 11.39
Net Profit Margin (TTM) -- -1,744.55 -18.01
Net Profit Margin - 5 Yr. Avg. -1,127.90 -178.80 7.65
Effective Tax Rate (TTM) -- 14.32 21.32
Effective Tax Rate - 5 Yr. Avg. -- 18.97 24.45

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,520,427 722,980,797
Net Income/Employee (TTM) -577,417 -3,918,019 83,628,555
Receivable Turnover (TTM) -- 8.33 5.19
Inventory Turnover (TTM) -- 2.80 4.12
Asset Turnover (TTM) 0.00 0.47 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.70 -0.91 10.15
Return on Assets - 5 Yr. Avg. -47.89 2.43 10.82
Return on Investment (TTM) -45.44 -0.53 12.77
Return on Investment - 5 Yr. Avg. -63.52 2.24 13.88
Return on Equity (TTM) -94.54 -3.22 14.47
Return on Equity - 5 Yr. Avg. -81.57 -1.62 15.19
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 44.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cyclacel Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.69%
# of Holders: 21
Total Shares Held: 682,697
3 Mo. Net Change: -322
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.